Medicare Enrolled

Dr. Bhadresh Nayak, MD

Hematology & Oncology · Sterling Heights, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
43243 SCHOENHERR RD, Sterling Heights, MI 48313
5862683100
Registered in NPPES since 2006
NPI: 1295708980 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nayak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nayak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nayak

Dr. Bhadresh Nayak is a hematology & oncology specialist in Sterling Heights, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nayak performed 15,629 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Nayak received a total of $1,194 from 19 pharmaceutical and/or device companies across 44 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nayak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 19% volume in MI $1,194 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
15,629
Medicare services
Top 19% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
2,705 $8 $12
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
2,695 $7 $19
Denosumab injection (Prolia/Xgeva) 2,100 $18 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,556 $64 $110
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 1,550 $1 $8
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
1,393 $65 $116
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
990 $6 $59
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
517 $98 $154
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
467 $10 $44
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
400 $5 $211
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
294 $40 $88
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
277 $6 $67
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
193 $104 $204
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
153 $138 $302
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
77 $18 $55
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
72 $1 $5
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
65 $47 $192
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $126 $253
New patient office visit, complex (60-74 min) 24 $173 $319
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
24 $95 $275
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $79 $187
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
11 $148 $248
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
37.5% medium
62.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,194
Total received (2018-2024)
Avg $199/year across 6 years
Bottom 47% in MI for hematology & oncology
19
Companies
44
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$190
2023
$200
2022
$100
2021
$12
2019
$24
2018
$668

Payments by company (2024)

Astellas Pharma US Inc
$100
Incyte Corporation
$90
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$400
Medtronic Vascular, Inc.
$115
Lilly USA, LLC
$106
Incyte Corporation
$90
Boston Scientific Corporation
$74
Genentech USA, Inc.
$68
Amgen Inc.
$47
Janssen Biotech, Inc.
$40
PFIZER INC.
$39
AstraZeneca Pharmaceuticals LP
$33
AMAG Pharmaceuticals, Inc.
$27
E.R. Squibb & Sons, L.L.C.
$24
Gilead Sciences, Inc.
$23
Agios Pharmaceuticals, Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
Celgene Corporation
$18
Alexion Pharmaceuticals, Inc.
$18
Novartis Pharmaceuticals Corporation
$16
Teva Pharmaceuticals USA, Inc.
$16
Top 3 companies account for 52.0% of all-time payments
Associated products mentioned in payments ›
Abraxane · Alecensa · Avastin · BENDEKA · BRAFTOVI · CYRAMZA · DARZALEX · FERAHEME · IMFINZI · Kyprolis · Neulasta · OPDIVO · PROMACTA · RESONATE · Resolute · SOLIRIS · SPRYCEL · TAGRISSO · TALZENNA · TECENTRIQ · TIBSOVO · VERZENIO · XALKORI · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Sterling Heights?
Compare hematology & oncology specialists in the Sterling Heights area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
116
County median income
$76,399
Nearest hospital to ZIP centroid (approximate)
HENRY FORD MACOMB HOSPITAL
2.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nayak is a mixed practice specialist, with above-average Medicare volume (top 19% in MI), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nayak experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Nayak performed 2,705 blood draw (venipuncture) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nayak receive payments from pharmaceutical companies?
Yes. Dr. Nayak received a total of $1,194 from 19 companies across 44 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nayak's costs compare to other hematology & oncology specialists in Sterling Heights?
Dr. Nayak's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nayak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →